INTRODUCTION
Chitin, a polymer of b-1,4-N-actetylglucosamine and a widespread polysaccharide constituent of arthropods, parasites, and fungi, is among the few molecular agents described to induce innate type 2 reactions accompanied by eosinophils and alternatively activated macrophages (AAMs) (Reese et al., 2007) . In fungi, chitin complexes with b-glucans, galactomannans, and mannoproteins to form the hyphal cell wall (Fontaine et al., 2000) , and in house dust mites and other insects, chitin comprises both the exoskeleton and peritrophic matrix, forming a lattice with mucins and proteins containing chitin-binding peritrophin domains such as the allergen Der p 23 (Hegedus et al., 2009; Weghofer et al., 2013) . The response to chitin is characterized by recombinase activating gene (RAG)-independent tissue accumulation of eosinophils, which is attenuated by the STAT6-inducible mammalian chitinase AMCase (Reese et al., 2007; Van Dyken et al., 2011) . Chitin also leads to Arg1 expression in mouse macrophages, a marker for IL-4-and IL-13-activated AAMs, which are associated with eosinophils in a variety of physiologic settings . The pathways underlying the induction of these cell types by chitin, however, remain incompletely defined.
Type 2 innate lymphoid cells (ILC2s) are systemically dispersed tissue cells in humans and mice and produce IL-5 and IL-13 in response to epithelial-associated cytokines such as thymic stromal lymphopoietin (TSLP), IL-25, and IL-33 (reviewed in Walker et al., 2013) . Exogenous administration or transgenic expression of any of these epithelial cytokines results in exaggerated type 2 immune pathology in the lung, suggesting roles in the initiation of allergic immunity (Fort et al., 2001; Schmitz et al., 2005; Zhou et al., 2005) . Lung inflammation can be induced by the plant-derived proteinase papain by an unknown mechanism but is attenuated in broadly immunodeficient mice that lack ILC2s (Halim et al., 2012) . It remains to be established whether active papain resembles fungal-derived proteinases, which generate fibrinogen cleavage products to activate Toll-like receptor 4 (TLR4) in the airways (Millien et al., 2013) . Nevertheless, chitin mediates eosinophilia in a TLR4-independent manner (Reese et al., 2007) , and the relative contributions of IL-25, IL-33, and TSLP to ILC2 function in vivo remain unresolved. Here, we dissect the network of cytokines produced in response to chitin, a natural constituent of inhaled allergens, to reveal a nonredundant role for these three epithelial cytokines in activation of resident ILC2s to produce cytokines mediating eosinophil and AAM accumulation. Unexpectedly, chitin also generated a separate suite of cytokines implicated in the activation of resident gd T cells that produce IL-17A and mediate neutrophil accumulation. Genetic ablation of ILC2s resulted in enhanced gd T cell activation and prolonged neutrophil recruitment to tissues, revealing a previously unappreciated interaction between innate lymphoid cell activation and the control of specific types of infiltrating myeloid effector cells.
RESULTS

Chitin Induces Focal Clustering of Type 2 Innate Immune Cells in Lung Tissue
Chitin particles induce innate inflammatory responses in lung tissue characterized by eosinophils and Arg1-expressing AAMs (Reese et al., 2007) ; however, differences in particle size, concentration, and source material impart variability to these responses (Da Silva et al., 2009) . To dissect these mechanistic components, we size-fractionated endotoxin-free pure chitin beads to a range of 50-70 mm and administered a standard intranasal dose daily for 2 days before analysis the following day ( Figure 1A ). Treatment with chitin, but not similarly sized beads of synthetic polymers such as polystyrene (PS) or polymethylmethacrylate (PMMA), resulted in robust accumulation of lung eosinophils and Arg1-reporter (Yarg)-positive AAMs (Figures 1B  and 1C ; Figure S1A available online), supporting earlier findings (Reese et al., 2007) and confirming specificity of the response to the polysaccharide chitin. Fluorescently labeled chitin was visualized in situ 1 hr after instillation via 2-photon live lung slice imaging (Thornton et al., 2012) and immunohistology, but no chitinassociated inflammation was apparent at this time point (Movie S1). Within 2-3 hr, however, chitin beads were surrounded by focal inflammatory cell clusters that consisted of numerous motile c-fms + myeloid cells (Movie S2) and cells that appeared to be eosinophils, because they expressed the Il4 4get/4get reporter allele (Mohrs et al., 2001 ) and were absent in eosinophildeficient Il4 4get/4get Gata1 DdblGATA/DdblGATA mutant mice, which lack eosinophils because of a mutation in the high-affinity, palindromic ''double'' GATA protein binding site of the Gata1 promoter ( Figure 1D ; Yu et al., 2002) . Subsequently, 12-24 hr after chitin but not PS administration, Arg1-expressing AAMs were also present in inflammatory foci coincident with degradation of the chitin particles ( Figure 1E ; Movies S3, S4, and S5).
Type 2 Cytokine Production Contributes to AAM and Eosinophil Accumulation Eosinophils and AAMs are hallmarks of polarized type 2 tissue responses, and their rapid recruitment to chitin inflammatory clusters suggested an innate contribution of the canonical type 2 cytokines IL-4, IL-5, and IL-13, which control tissue maintenance of these cells in concert with chemokines and lipid mediators (Reese et al., 2007; Rothenberg and Hogan, 2006; Van Dyken and Locksley, 2013) . We tested the specific involvement of IL-4 and IL-13 by administering chitin to mice lacking IL-4 (homozygous Il4 KN2/KN2 reporter mice, which contain a gene encoding a nonsignaling human CD2 reporter element inserted at the Il4 start site that thereby prevents endogenous Il4 gene expression) (Mohrs et al., 2005) , both IL-4 and IL-13 (Il4
), or the shared signaling component STAT6 (Stat6 À/À ). The genetic absence of IL-4 alone did not affect eosinophil or AAM numbers, and we found no expression of the IL-4 KN2 reporter after chitin administration (data not shown).
In contrast, we observed decreased numbers of lung eosinophils and AAMs in the combined absence of IL-4 and IL-13, implicating an IL-13-mediated contribution (Figures 2A and 2B ). Chitin administration also led to an increase in lung expression of eotaxin-1 (CCL11), a chemokine previously linked to eosinophil recruitment via IL-13 activity, and mice lacking the eotaxin-1 receptor CCR3 exhibited a decreased eosinophil response (Figure S2) . Although the absence of the transcription factor STAT6 did not impact eosinophil numbers, in agreement with prior findings (Reese et al., 2007) , STAT6 was required for AAM induction ( Figure 2B ), suggesting that IL-13 signaling via STAT6 increases Arg1 expression in macrophages but also mediates STAT6-independent effects on eosinophil accumulation. To identify cellular sources of IL-13 in lung tissue after chitin exposure, we used Il13
Smart/Smart mice, whose cells contain a nonsignaling huCD4 surface marker downstream of an IRES inserted in the 3 0 region of the endogenous Il13 gene, thus sustaining normal expression . Lung cells from unchallenged mice expressed no detectable IL-13 reporter activity. After chitin, ILC2s, but no other immune cells, were robustly positive for the huCD4 IL-13 reporter, consistent with their expression of IL-13 in situ ( Figures 2C and S3 ). IL-13 protein was also present in culture supernatants from ILC2s sorted from the lungs after chitin ( Figure 2D ); IL-13 was not detected in serum (data not shown). Increased IL-13 production by ILC2s correlated with their increased recovery that occurred even in the absence of IL-4 and/or IL-13 or STAT6 ( Figure 2E ) and coincided with elevated expression of CD25 and CD69 ( Figure 2F ). Thus, chitin activates ILC2s to produce local IL-13 that contributes to the in vivo accumulation of eosinophils and AAMs.
IL-5 Expression Identifies Lung ILC2s
In Vivo and Mediates Eosinophil, but Not AAM, Accumulation in Response to Chitin The activation of IL-13 expression by lung ILC2s in response to chitin led us to examine the involvement of IL-5, an ILC2-associated type 2 cytokine critical for eosinophilia in the context of allergen exposure and helminth infection. By using IL-5 reporter mice that express RFP (tdTomato) and Cre recombinase from the Il5 start site (Il5 Red5/Red5 ) , we noted that many lung ILC2s were RFP + under resting conditions. After chitin administration, however, IL-5 expression increased (Figures 3A and 3B) . Similar to IL-13, IL-5 expression was restricted to ILC2s and appeared in no other cells ( Figure S4 ). We tested whether chitin-induced IL-5 expression by ILC2s could be modulated by acidic mammalian chitinase (AMCase), a STAT6-dependent enzyme involved in chitin degradation (Reese et al., 2007; Van Dyken et al., 2011) . When administered to mice that expressed enhanced lung levels of AMCase (SPAM mice) (Reese et al., 2007) , chitin no longer induced IL-5 reporter expression in lung ILC2s ( Figure 3C ), thus genetically positioning intact chitin upstream of ILC2 activation and suggesting that AMCase induction limits the duration of the inflammatory response.
Lung imaging during chitin challenge revealed IL-5-expressing ILC2s in close proximity with medium-to-large blood vessels containing VCAM1 + endothelial cells ( Figure 3D ) and with airways in which collagen was evident by second harmonic generation via 2-photon microscopy ( Figure S5 , Movies S6, S7, S8, and S9). Consistent with the association between IL-5-expressing ILC2s and the vasculature, we observed increased serum IL-5 levels after chitin ( Figure 3E ), supporting a dual role for ILC2s in mediating both local and systemic effects on eosinophils. Indeed, IL-5 was critical for eosinophil accumulation after chitin challenge, as indicated by the fact that mice lacking IL-5 (homozygous Il5 Red5/Red5 ) had normal numbers of lung ILC2s but diminished numbers of eosinophils after chitin challenge ( Figures 3F and 3G ). In contrast, IL-5 deficiency had no impact on chitin-induced AAM accumulation, as shown by the fact that Il5
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Yarg/Yarg mice had wild-type numbers of Arg1-expressing AAMs (Figure 3H) , thereby dissociating the effects of IL-5 and eosinophils from that of IL-13 and AAMs. The impairment of eosinophils in the absence of either IL-5 or IL-13 implied that these two ILC2-derived cytokines cooperate to mediate nonredundant aspects of eosinophil production, recruitment, and/or retention in response to chitin. Taken together, these results indicated that inhaled chitin provoked local accumulation of both eosinophils and AAMs by stimulating innate production of type 2 cytokines from ILC2s, which could be attenuated by increased local chitinase activity.
Genetic Deletion of ILC2s Abolishes Chitin-Induced Eosinophil and AAM Accumulation but Enhances Innatelike T Cell and Inflammatory Cytokine Responses
The expression of IL-5 and IL-13 solely by lung ILC2s in response to chitin enabled us to test the role of these cells in eosinophil and AAM accumulation by using cytokine-mediated cell deletion. challenge, both IL-5 (RRDD) and IL-13 (YYDD) deleter strains had reductions in lung ILC2 numbers that resembled levels in ILC2-deficient Il2rg À/À Rag2 À/À mice after chitin, confirming that cytokine expression in these cells results in their specific elimination ( Figure 4A ). ILC2 deletion driven by either IL-5 or IL-13 resulted in severely diminished numbers of both eosinophils and AAMs in response to chitin and resembled the reductions observed in Il2rg Figures 4B and 4C ). Together, these data demonstrate that IL-5-and IL-13-producing ILC2s mediate the accumulation of eosinophils and AAMs in response to chitin. Notably, the ILC2 deletion efficiency was comparable in both cytokine deleter strains ( Figure 4A ), suggesting that a majority of ILC2s express both IL-5 and IL-13 in response to chitin challenge. Although eosinophils and AAMs localized to chitin in lung tissue, we also noted the recruitment of additional cells ( Figures  1D and 1E ), suggesting the induction of additional inflammatory signals. Indeed, the inflammatory cytokines IL-1b and IL-17A were induced in lung tissue within 6 hr of chitin treatment (Figure 5A ). Because lung-resident innate-like gd T cells rapidly produce IL-17A in response to IL-1b and/or IL-23 administration, we examined whether these cells were activated during chitin challenge by using IL-17A, IFN-g dual reporter mice (Price et al., 2012) . In contrast to CD4 + T cells, a proportion of lung gd T cells expressed IL-17A, but not IFN-g, in response to intranasal chitin ( Figure 5B ). Unexpectedly, ILC2 deletion resulted in altered kinetics and elevated expression of several inflammatory cytokines in lung tissue after chitin challenge, including TNFa, IL-1b, IL-23, and IL-17A ( Figure 5C ), consistent with a heightened gd T cell response. In support of this, lung gd T cells that produced IL-17A in response to chitin coexpressed the activation marker CD69 ( Figure 5D ), and we detected increased total gd T cell numbers in the lungs of RRDD mice after chitin challenge along with an elevated CD69 + proportion among these cells ( Figure 5E ).
These alterations were accompanied by increased accumulation of neutrophils in ILC2-deficient RRDD mice as compared to wild-type and IL-5-deficient (Il5 Red5/Red5 ) controls; however, this response was abrogated by treatment of RRDD mice with a gd TCR antibody (UC7-13D5), resulting in a reduction of neutrophils to levels observed in mice deficient in either T cells (Rag2 Figure 5F ), thereby implicating
ILC2s in the suppression of exacerbated inflammatory cytokine signaling and gd T cell activation in response to chitin. Intriguingly, gd T cell and neutrophil numbers were unaltered as compared to control animals after chitin treatment in both Il4
Il13
À/À and Il5 transgenic mice that contain excessive amounts of eosinophils ( Figure 5F and data not shown). Thus, enhanced gd T cell activation and neutrophil accumulation that occurred in the absence of chitin-activated ILC2s was not due to the loss of ILC2 IL-5 and IL-13 production or the absence of eosinophils and AAMs. These results indicated that chitin activated both ILC2s and innate-like gd T cells to mediate downstream inflammatory cell recruitment but that crosstalk between these two cell types, as revealed by specific in vivo deletion of ILC2s, was independent of ILC2-derived type 2 cytokines.
Chitin Administration Induces Lung TSLP, IL-25, and IL-33 Expression The dual activation of innate ILC2s and innate-like gd T cells by chitin suggested that distinct modules of epithelial cytokines could account for the accumulation of different inflammatory myeloid cells. ILC2s produce type 2 cytokines after administration of IL-25, IL-33, and TSLP, which are epithelial-associated cytokines implicated in type 2 immunity (Walker et al., 2013) . We assayed production of these cytokines in lung tissue to determine their roles in ILC2 stimulation in response to chitin. We detected increased amounts of lung IL-33 protein after intranasal chitin, in agreement with a previous study (Yasuda et al., 2012 ), but we also documented induction of TSLP in lung tissue and IL-25 in bronchoalveolar lavage (BAL) during overlapping time periods (Figures 6A and 6B ). Lung ILC2s expressed cytokine receptor subunits specific for IL-25, IL-33, and TSLP under resting conditions ( Figure 6C ), but the steady-state numbers of lung ILC2s were unaltered in mice genetically deficient in TSLPR (Crlf2 À/À ), IL-25 (Il25
) ( Figure 6D ). Thus, multiple cytokines with potential ILC2-stimulating activity were produced in response to chitin and lung ILC2s were poised to respond to any or all of these cytokines.
Lung ILC2s Are Present in the Combined Absence of TSLPR, IL-25, and IL-33R but Fail to Produce IL-5 and IL-13 in Response to Chitin Combinations of TSLP, IL-25, and IL-33 might act together to regulate ILC2s (Halim et al., 2012; Hardman et al., 2013; Neill et al., 2010) , but the in vivo contributions of these cytokines to ILC2 function have not been comprehensively explored. We generated an inbred cohort of mice with single or combined Data are presented as mean ± SEM, n = 4-6/ group; **p < 0.0001 (unpaired t test), as compared to WT control.
deficiencies in TSLPR, IL-25, and IL-33R to determine their contributions to ILC2 expansion and function during the innate chitin response. In the steady-state, ILC2s developed and populated the lung in normal numbers even in the total absence of TSLPR, IL-25, and IL-33R (Crlf2
( Figure 7A ). After chitin administration, however, mice lacking IL-33R showed significantly reduced numbers of lung eosinophils ( Figure 7B ), corroborating results obtained in IL-33-deficient mice (Yasuda et al., 2012) , and this was accompanied by fewer AAMs. Unexpectedly, similar reductions in eosinophils and AAMs occurred in mice deficient in TSLPR or IL-25, as well as in mice with compound deficiencies of any two of these factors. The combined absence of all three factors in Crlf2
in substantial attenuations of eosinophils and AAMs in response to chitin ( Figures 7B and 7C) . Thus, each of these cytokines has a nonredundant role in the innate response to chitin, yet each can play a compensatory role in the combined absence of the other two pathways. Despite downstream effects on eosinophil and AAM accumulation, the absence of these epithelial activating signals alone or in combination had no effect on either the resting numbers of lung ILC2s or their enhanced recovery during the 48 hr after chitin exposure, including in Crlf2 Figure 7A ). In contrast to the response observed in ILC2-deleted mice ( Figures 5C-5F ), signals involved in the recruitment and maintenance of other inflammatory cell types were unaffected in the Crlf2
mice, as shown by the fact that neutrophil influx ( Figure 7D ), gd T cell numbers, and induction of IL-1b and TNFa in the lung tissue and BAL were unaffected ( Figure 7E ; data not shown). Consistent with the deficiencies in eosinophils and AAMs, ILC2s sorted from chitin-exposed Crlf2
deficient mice produced no detectable IL-5 and IL-13 as compared to equal numbers of purified wild-type ILC2s (Figure 7F) . Intriguingly, even after stimulation with ionomycin + PMA in vitro, ILC2s sorted from the various deficiency settings produced reduced amounts of IL-5 and IL-13 that corresponded to their respective in vivo impairments in mediating eosinophil and AAM accumulation ( Figure 7G ). Thus, these epithelial cytokines coordinately regulate ILC2 cytokine production and accumulation of innate type 2 myeloid cells in response to chitin through nonredundant yet partially overlapping pathways that are distinct from simultaneously induced mechanisms that mediate the recruitment and maintenance of other inflammatory cell types. In sum, these results indicate that innate and innate-like lymphoid cells operate in parallel and are poised to respond to multiple epithelial inputs that cooperate to influence their activation and function.
DISCUSSION
Our results define innate pathways of ILC2 and innate-like T cell activation induced by the polysaccharide chitin, a widespread environmental constituent derived from arthropods, fungi, and helminth parasites. The primary initiators of the ILC2 response in vivo are the epithelial-associated cytokines IL-25, IL-33, and TSLP, which, as we show here, are each induced by chitin and are together required to stimulate ILC2 production of IL-5 and IL-13. The latter two cytokines, in turn, are required for accumulation of canonical innate cells, eosinophils and AAMs, that are associated with allergy. Because the production of these two cytokines is restricted to ILC2s during the chitin response, we utilized genetic markers and function-based deletion to demonstrate that IL-13 mediates AAM accumulation by a STAT6-mediated process, whereas both IL-13 and IL-5 mediate eosinophilia by a partially STAT6-independent process. The comparable effects achieved in the two cytokine-based deletion strains suggest that individually activated ILC2s produce both cytokines in response to chitin and distinguish ILC2s as essential regulators of lung eosinophil and AAM accumulation. Notably, this method of cytokine-mediated depletion of ILC2s achieved highly specific elimination of these cells with minimal in vivo manipulation, revealing unexpected effects on innate-like gd T cells and indicating utility in future studies of ILC2 function, which heretofore has relied primarily on either nonspecific and incomplete antibody-mediated or bone-marrow reconstitution approaches or the use of broadly immunodeficient (e.g., Il2rg
Rag2
À/À ) mouse strains (Halim et al., 2012; Monticelli et al., 2011; Wong et al., 2012; Roediger et al., 2013 ). These findings demonstrate rigorously that ILC2s in the lung, and possibly in other organs, function as sentinel cells capable of processing multiple epithelial-derived signals to activate cytokines that mediate inflammatory cell recruitment. Although a close relationship between AAMs and eosinophils has been previously reported (Reese et al., 2007; Van Dyken and Locksley, 2013; Voehringer et al., 2007) , the involvement of a common upstream regulator of both these cell types in the lung has not been established. Although lung ILC2s have been linked to the eosinophilic response to papain, their in vivo relationship to other innate cells and regulation by epithelial cytokines could not be resolved via lung explant cultures (Halim et al., 2012) . Obtained by in situ tissue imaging, our results indicate that lung ILC2s are positioned to relay signals emanating from epithelia to the endothelium, where recruitment, retention, and/or survival signals would affect infiltrating inflammatory cells. Red5 + ILC2s
were closely associated with vessels expressing VCAM-1, consistent with the role for eosinophil VLA-4 (a4b1 integrin)-mediated recruitment during allergic lung inflammation (Rothenberg and Hogan, 2006) . Although numbers were drastically reduced, we did not observe complete elimination of chitin-induced AAMs and eosinophils even in the ILC2-deficient (Il2rg
À/À ) mice. Thus, additional ILC2-independent mechanisms can mediate residual ; also see Figure S1 ) in left lung lobe tissue (D) and IL-1b protein levels in lung tissue lysate (E) 24 hr after intranasal treatment with PBS or chitin. (F and G) IL-5 and IL-13 protein levels in supernatant from sorted lung ILC2s from WT or Crlf2
Il1rl1
À/À triple-deficient mice after in vivo chitin treatment, cultured in the presence of IL-7 (F) or ionomycin/PMA (G). NS indicates not statistically significant; ND indicates none detected. Data are presented as mean ± SEM, n = 3-5/group; *p < 0.001; **p < 0.0001 (unpaired t test), compared to chitin-treated WT control.
recruitment or retention of these cells, possibly via epithelial production of CCL2 (Roy et al., 2012) , macrophage-derived LTB 4 (Reese et al., 2007) , or STAT6-independent induction of Arg1 in the case of macrophages (Qualls et al., 2010) . Although STAT6 expression has been linked with ILC2 proliferation in response to fungal challenge (Doherty et al., 2012) , we found that neither STAT6 nor IL-4 and IL-13 were necessary for the expansion and activation of ILC2s in response to chitin, consistent with earlier findings made during nematode infection . Taken together, however, these data support a predominant role for ILC2-derived type 2 cytokines in mediating eosinophil and AAM accumulation after chitin exposure. Intriguingly, we observed a similar relationship among ILC2s, eosinophils, and AAMs in maintaining visceral adipose tissue homeostasis , suggesting that these innate type 2 immune circuits are also engaged in certain tissues under basal conditions. As previously reported , some resident lung ILC2s spontaneously express IL-5 in the resting state but were further induced by chitin to express IL-13 and additional IL-5. We analyzed intercrossed lines of mice that lacked TSLPR, IL-25, or IL-33R alone or in all possible combinations, including Crlf2
À/À triple-deficient mice. Unexpectedly, each of the three pathways contributed in a nonredundant fashion to the optimal induction of ILC2 cytokines and the infiltration of lung tissues with eosinophils and AAMs in response to chitin. Absence of all three cytokines led to almost complete loss of ILC2 cytokine secretion and innate type 2 inflammatory cell accumulation. This impairment occurred independently of a parallel program mediating the tissue infiltration of other inflammatory cells, as indicated by the fact that IL-1b production and neutrophil recruitment in response to chitin were normal in Crlf2
À/À triple-deficient mice. In contrast, these other inflammatory responses were enhanced in the ILC2 deleter mice, suggesting that, although canonical type 2 cytokine signals can inhibit IL-17A-driven neutrophilia and acute lung damage in the context of parasite infection (Chen et al., 2012) , activated ILC2s generate factors other than IL-5 and IL-13 that inhibit gd T cell activation and neutrophil recruitment. ILC2s can produce mediators such as amphiregulin that have been implicated in lung epithelial repair after virus-induced injury (Monticelli et al., 2011) , although we could not detect amphiregulin induction nor did exogenous treatment with amphiregulin have inhibitory effects on the enhanced chitin-mediated inflammatory response in ILC2 deleter mice (data not shown).
Although further experiments will be required to assess the cell-intrinsic nature of the epithelial cytokine receptor pathways on ILC2s, we document that each of these receptors is expressed on lung ILC2s. Synergistic effects of TSLP and IL-33 on cultured ILC2s have been reported (Halim et al., 2012) and combined IL-25 and IL-33 signals contributed to ILC2 expansion during helminth infection (Neill et al., 2010) and in response to fungal extracts (Hardman et al., 2013) , but the in vivo absence of all three signaling pathways has not previously been explored. As assessed by this innate lung response, the numbers of ILC2s recovered from tissues before and after chitin were unaffected in Crlf2
À/À triple-deficient mice, suggesting that these cytokines are not required for the development of ILC2s.
ILC2s from triple-deficient mice, however, had impaired cytokine responses to PMA/ionomycin stimulation in vitro. Because this challenge bypasses receptor signaling pathways, the possibility remains that terminal differentiation of ILC2s is dependent on epithelial cytokines produced in situ. These findings must be further addressed in light of the possible role of Th2 cells in overcoming the dependence on epithelial cytokines in adaptive type 2 immune responses, because important roles for CD4 T cells in ILC2 expansion and activation have also been described (Wilhelm et al., 2011) .
Our data support a model in which an epistatic cascade of signals initiated at the epithelium converges on ILC2s, which respond by altering the local microevironment to establish conditions conducive to specific immune cell retention and alleviation of the chitin stimulus through particle degradation. This multicomponent signal is mainly comprised of TSLP, IL-25, and IL-33, but additional signals as well as the mechanisms governing the production and release of these cytokines remain under investigation. As such, innate sources aside from epithelial cells could possibly contribute or respond to TSLP, IL-25, and IL-33, including basophils (Kroeger et al., 2009; Sokol et al., 2008) , macrophages, and inflammatory dendritic cells (WillsKarp et al., 2012) among others (reviewed in Bartemes and Kita, 2012) . In response to chitin stimulation, however, expression of IL-5 or IL-13 was restricted to ILC2s, whereas IL-4, which can be produced by basophils in vivo during helminth infection (Sullivan et al., 2011) and allergic skin inflammation (Egawa et al., 2013) , was not required for the accumulation of eosinophils or AAMs. The kinetics of the response, along with the positioning of lung ILC2s, is consistent with initiation at the subepithelial barrier, which may be compromised by intact chitin particles. In this respect, IL-33, a nuclear factor that can be biologically active in full-length form and lacks a signal peptide for secretion, has been suggested to act as an ''alarmin'' released during necrosis (Lü thi et al., 2009) , as occurs in response to elevated extracellular ATP (Kouzaki et al., 2011) or because of mechanical stress (Kakkar et al., 2012) . Subsequent processing may also be relevant, because cleavage events can enhance the cytokine activity of both IL-25 (Goswami et al., 2009) and IL-33 (Lefranç ais et al., 2012) , whereas IL-33 is inactivated by proapoptotic caspases (Lü thi et al., 2009) . Intriguingly, TSLP induces STAT5 and GATA3 in human ILC2s and mediates functional synergism with IL-33 (Mjö sberg et al., 2012) in a manner echoing the antigen-independent activation of Th2 cells (Guo et al., 2009 ), suggesting that similar mechanisms may be engaged during innate and adaptive type 2 inflammation. Activation of this innate pathway warrants further studies of its role in mediating allergic inflammatory responses to chitin-containing particles and organisms, particularly in regard to its effects on adaptive Th2 cell induction and the role of induced chitinase and chi-lectins in terminating the response.
EXPERIMENTAL PROCEDURES Mice
Mice were maintained under specific-pathogen-free conditions and all procedures were approved by the UCSF IACUC. Il1rl1 À/À mice (Hoshino et al., 1999) were backcrossed eight generations to BALB/c (Jackson Laboratories) before intercrossing with Il25 À/À (Fallon et al., 2006) ,
Smart/Smart (Price et al., 2012) , Il5 Red5/Red5 , and others described in the Supplemental Experimental Procedures.
In Vivo Treatments
Pure chitin beads (New England Biolabs; NEB) ranging from 50 to 70 mm in diameter were prepared by size filtration through nylon mesh, washed, and reconstituted in sterile PBS (Ca 2+ , Mg 2+ free) at a final concentration of 10 5 chitin beads/ml. Mice were briefly anesthetized with isofluorane, and 50 ml of this suspension (5,000 beads) was aspirated by intranasal administration, followed by euthanasia and analysis at various time points after instillation. Precision size standard 60 and 90 mm polystyrene beads (Polysciences) as well as 83 mm polymethylmethacrylate beads (Bangs Laboratories) were prepared and administered identically. For in vivo anti-gd T cell treatment, purified UC7-13D5 gd TCR antibody (0.25 mg) was administered to mice intraperitoneally 24 hr prior to intranasal chitin.
Tissue Preparation and ILC2 Sorting
Whole lungs were perfused with 20 ml PBS via heart puncture before excising and preparing single-cell suspensions with an automated tissue dissociator (gentleMACS; Miltenyi Biotec), running program lung_01, followed by incubation for 35 min at 37 C in HBSS (Ca 2+ , Mg 2+ free) containing 0.2 mg/ml Liberase Tm and 25 mg/ml DNase I (Roche), then program lung_02. The tissue was further dispersed by passing through 70 mm nylon filters, washing, and subjecting to red blood cell lysis (PharmLyse; BD Biosciences) before final suspension in PBS/2% fetal calf serum. Cells were stained for flow cytometry and cultured as described in the Supplemental Experimental Procedures.
Protein Analysis and Bronchoalveolar Lavage
Lungs were instilled with 1 ml PBS to collect bronchoalveolar lavage (BAL), which was centrifuged, and supernatant was concentrated with Amicon Utra-4 filters as recommended (MWCO 10 kDa; EMD Millipore) prior to protein analysis by enzyme-linked immunoassay (ELISA) specific for IL-25 (eBioscience). Whole-lung lysates were prepared in M tubes (Miltenyi Biotec) containing TNT lysis buffer and protease inhibitor tablets (Complete; Roche) via an automated tissue dissociator as recommended (gentleMACS; Miltenyi Biotec). Total protein content was determined by BCA (Pierce) and equal protein amounts were assayed for TSLP, IL-33, eotaxin-1, and IL-23p19 by ELISA (R&D Systems). Amounts of IL-5 and IL-13 in ILC2 culture supernatants, as well as TNFa, IL-1b, IL-12/23 p40, and IL-17A levels in total lung lysates, were quantified by cytometric bead array (CBA) via an LSRII flow cytometer and FCAP Array analysis software (BD Biosciences).
Immunohistology
Lungs were fixed in 4% paraformaldehyde, immersed in 30% sucrose, and then embedded in OCT compound (Sakura Finetek) prior to frozen sectioning at 6 mm via a Leica CM 3050S cryomicrotome (Leica Microsystems). Amplification and detection of YFP and GFP signals were performed as described (Reese et al., 2007) , and tdTomato fluorescence in Il5 Red5/Red5 mice was directly visualized without amplification. Chitin was detected with FITC-and rhodamine-conjugated chitin-binding domain probes (NEB) (Van Dyken et al., 2011) and images were acquired with an AxioCam HRm camera and AxioImager M2 upright microscope (Carl Zeiss).
Statistical Analysis
Statistical analysis was performed as indicated in figure legends by Prism software (GraphPad). 
SUPPLEMENTAL INFORMATION
